Federal Reserve's Barkin: It's a "hard-to-assert" question whether interest rates are sufficiently high.

Offshore oil and gas module equipment provider VME (VME.US) aims to go public on Nasdaq, planning to raise up to 30 million US dollars.

Hypertension drug developer Retension (RTSN.US) applies for U.S. listing, aiming to raise $58 million

Pfizer (PFE.US) to share overseas price increase gains with the U.S. government: “Most Favored Nation” contract revealed, over twenty transactions remain confidential

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US IPO, aims to raise up to 100 million dollars